Searches for a Zepbound coupon outnumber the equivalent searches for Wegovy and Mounjaro, which makes sense: Zepbound produces the largest average weight loss of the approved medications and carries a list price most people cannot absorb. Eli Lilly does run a savings card, and it is genuinely useful. It also has two conditions that decide what you actually pay, and neither is in the headline.
The condition worth reading first
If you are paying out of pocket and taking 7.5 mg or above, the discounted price of $449 for a one-month supply is conditional on refilling within 45 days of the date your previous fill was delivered or received. Refill later than that and the offer does not apply, and the regular price for those doses is $699.
That is a $250 difference per month, decided by a calendar.
What makes it a trap rather than a rule is that the two most common reasons for missing the window are not decisions. The first is dose titration: moving up a dose can mean a new prescription, a new prior authorisation, or simply a gap while the pharmacy sources the new strength. The second is supply and shipping delay, which is outside your control entirely.
The practical response is unglamorous and effective: order the refill on day 25 to 30 rather than when you run out. A one-month supply is four pens, and having a few days of overlap costs nothing while a late refill costs $250.
"As little as $25" is capped at $100
The headline offer for people with commercial insurance that covers Zepbound is "pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill". That is true and it is also the best case, because the savings themselves are capped:
- $100 maximum saving on a 1-month fill
- $200 maximum on a 2-month fill
- $300 maximum on a 3-month fill
- $1,300 maximum per calendar year
Read those two facts together and the arithmetic is straightforward. You reach $25 only if your plan already leaves you owing $125 or less. If your plan's cost-share is $500 a month, the card removes $100 and you pay $400 — not $25.
This is not a criticism of the programme, which is doing what copay cards do. It is a correction to the expectation the headline creates, and it matters because people budget from the headline and then discover the cap at the pharmacy counter.
Two completely different offers under one name
As with the Mounjaro card, "the Zepbound savings card" is really two programmes, and which one applies to you is decided by your formulary rather than by anything you do.
| Plan covers Zepbound | Commercial plan without Zepbound coverage, or self-pay | |
|---|---|---|
| What you pay | As little as $25 per fill | $299 to $449 per month, by dose |
| Savings cap | $100 / $200 / $300 per 1-, 2- or 3-month fill | Set by the difference from list price |
| Annual cap | $1,300 | Up to 11 fills per year |
| Main catch | The cap, not the coverage | The 45-day refill window on 7.5 mg and above |
What each dose actually costs
These are the single-patient-use KwikPen prices for a one-month supply. A month is also available as four single-dose vials at the same price.
| Dose | With the savings card | Regular self-pay price | Difference |
|---|---|---|---|
| 2.5 mg | $299 | $299 | — |
| 5 mg | $399 | $399 | — |
| 7.5 mg | $449 | $499 | $50 |
| 10 mg | $449 | $699 | $250 |
| 12.5 mg | $449 | $699 | $250 |
| 15 mg | $449 | $699 | $250 |
Two things stand out. The starting doses are the same either way, so the card does nothing for someone in their first month — which is exactly when people go looking for it. And the offer is worth most at 10 mg and above, which is where the 45-day rule also bites hardest. The card matters most precisely where it is easiest to lose.
For how these prices compare with the alternatives, see Zepbound cost per month, Zepbound and Mounjaro without insurance and our GLP-1 cost index.
Who is excluded
The exclusion is the standard one across manufacturer copay programmes in the United States, and it is absolute rather than a matter of degree. You are not eligible if you are enrolled in any state, federal or government-funded healthcare programme. Lilly's terms name them: Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, the Department of Defense, the VA, and TRICARE.
This is not Lilly being restrictive. Federal anti-kickback law prohibits manufacturers from offering copay assistance to patients in government programmes, so every manufacturer card in the country carries the same exclusion. It also means the group most likely to be on a fixed income is the group the card cannot help.
The current card's benefits expire on 31 December 2026. Manufacturer programmes are re-issued with revised terms each year, so a figure quoted anywhere — including here — should be checked against Lilly's own page before you rely on it.
If you are excluded
The realistic routes, in the order worth trying:
- Pursue coverage first. A covered prescription beats every discount programme, and Zepbound's approval for obstructive sleep apnoea in adults with obesity opened a coverage path that did not exist when it was a weight-only product. See getting a GLP-1 covered.
- Self-pay at $299 to $449 is available without insurance at all, and for many people it is cheaper than the copay their plan would leave them with. It is worth calculating rather than assuming.
- Patient assistance is a different programme from a savings card — it supplies medication at no cost to low-income patients rather than discounting it. Lilly runs one; the mechanics of this category, and the income thresholds involved, are set out in our guide to patient assistance.
- Compare the alternatives honestly. If cost is the binding constraint, a different medication your plan does cover may beat an uncovered Zepbound. See Wegovy versus Zepbound and the Wegovy savings card.
The order to do things in
- Find out whether your plan covers Zepbound at all. That single fact decides which of the two offers applies to you and is worth a phone call before anything else.
- If it is covered, ask what your cost-share is. Only then can you tell whether the card takes you to $25 or takes $100 off something much larger.
- If it is not covered, compare the self-pay price for your dose against the copay you would pay under the plan. They are not always in the order you expect.
- Once you are on 7.5 mg or above, put the refill on a calendar at day 25 to 30. This is the single highest-value thing in this article.
- Re-check the terms in January. The card expires at the end of the calendar year and is re-issued with new numbers.
This article is educational and is not medical or financial advice. Programme terms, eligibility criteria and prices change frequently. Confirm current details with Lilly, your insurer, your pharmacy and your prescriber.
Scientific References
1 sourceReferences open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Editor, Modern Weight Science
Claudiu Gheorghe is the editor of Modern Weight Science. He is not a physician. His role is to synthesize peer-reviewed studies, clinical-trial data, and FDA prescribing information into clear, plain-language explanations, and to make sure every factual claim on the site traces back to a cited source. Any decision about starting, changing, or stopping a medication belongs with a licensed clinician who knows your history.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
How much does the Zepbound savings card actually save?
Less than the headline suggests for most people. If your commercial plan covers Zepbound, you may pay as little as $25 per fill — but savings are capped at $100 for a 1-month fill, $200 for 2 months, $300 for 3 months, and $1,300 per calendar year. That means $25 is only reachable if your plan already leaves you owing $125 or less. On a $500 cost-share, the card removes $100 and you pay $400.
What is the 45-day rule on the Zepbound savings card?
For self-pay patients on 7.5 mg or above, the discounted $449 price requires refilling within 45 days of the date your previous fill was delivered or received. Refill later and the regular price applies, which is $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. The most common reasons people miss the window are dose titration and pharmacy or shipping delays, so ordering at day 25 to 30 rather than when you run out is the practical safeguard.
How much is Zepbound without insurance?
With the savings card, $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg and above, for a one-month supply of the single-patient-use KwikPen or four single-dose vials. Without the card, the regular prices are $299, $399, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. Note that the starting doses cost the same either way, so the card does nothing in your first month.
Can I use the Zepbound coupon with Medicare or Medicaid?
No. Lilly's terms exclude anyone enrolled in any state, federal or government-funded healthcare programme, naming Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, the Department of Defense, the VA and TRICARE. This is not specific to Lilly — federal anti-kickback law prohibits manufacturer copay assistance for patients in government programmes, so every card in the US carries the same exclusion.
Does the Zepbound savings card expire?
Yes. The current card's benefits expire on 31 December 2026. Manufacturer programmes are re-issued each year with revised amounts, caps and conditions, so any figure quoted online — including in this article — should be checked against Lilly's own savings page before you budget around it.
Is the savings card the same as patient assistance?
No, and confusing them is common. A savings card discounts a prescription for people who can pay something, and requires commercial insurance or self-pay status. A patient assistance program supplies medication at no cost to low-income patients who cannot pay, and involves an application, income documentation and your prescriber. They serve different situations and have different eligibility rules.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.